Genetic Technologies Ltd - Bathi resik saben saham sajrone patang kuartal pungkasan GENE

Genetic Technologies serves as a global diagnostic partner, implementing genetic cancer risk screenings in clinics. The annual EPS (TTM) growth rate is currently trading in a sideways range, where the -53.10 metric determines the status of the parameter. Synergy with distributors via AI tests is advancing personalized medicine, while increasing sales of prostate and breast cancer diagnostics are reducing the impact of fixed costs.

GENE gtglabs.com: Bathi resik saben saham (EPS TTM) ing interval 11.02.2024 - 20.02.2024

GENE (Genetic Technologies Ltd): rincian analitis lan laporan miturut indikator

- rega pasar lan target rega analis:

Bagan bursa gtglabs.com|GENE - Prakiraan konsensus analis

- rincian nilai pasar emiten:

Kapitalisasi pasar Genetic Technologies Limited|GENE - Nilai Total Perusahaan

- indikator nilai buku ekuitas:

Aset Bersih saben Saham Genetic Technologies|GENE - Kapitalisasi Buku|Rasio Nilai Pasar marang Ekuitas gtglabs.com|GENE - Total Aset Perusahaan

- data utang lan likuiditas:

Utang marang Modal Genetic Technologies|GENE - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal gtglabs.com|GENE - Gunggung utang perusahaan|Utang-utang marang nilai buku Genetic Technologies|GENE - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Genetic Technologies|Koefisien jangkoan perantara gtglabs.com

- data bathi bisnis lan rasio investasi:

GENE - Bathi resik|Bathi mangsa ngarep Genetic Technologies|GENE - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Genetic Technologies Ltd|GENE - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan GTG Labs|GENE - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Genetic Technologies|GENE - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan gtglabs.com|GENE - Wutah bathi ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Genetic Technologies

- indikator dodolan lan pendapatan:

GENE - Pendapatan perusahaan|Prakiraan pendapatan perusahaan Genetic Technologies Limited|GENE - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Genetic Technologies Limited|GENE - Wutah dodolan YoY sajrone rolas wulan kepungkur

Pambiji fundamental perusahaan:GENE, Genetic Technologies

Barang utama Genetic Technologies Limited

The efficiency of integrating GeneType tests into medical practice is directly reflected in profit dynamics. This annual growth in basic net income per share (ttm) measures the percentage change in EPS over the last twelve months relative to the previous year. Analysis of this chart reveals the pace of business scaling and the stability of cash flows. Sharp fluctuations in the indicator signal revenue volatility from preventive genomics. Stable growth confirms the fundamental value of Genetic Technologies (GENE) assets.

Pesaing langsung